Skip to main content
Top
Published in: AIDS and Behavior 4/2016

01-04-2016 | Original Paper

Condoms, Lubricants and Rectal Cleansing: Practices Associated with Heterosexual Penile-Anal Intercourse Amongst Participants in an HIV Prevention Trial in South Africa, Uganda and Zimbabwe

Authors: Zoe Duby, Miriam Hartmann, Elizabeth T. Montgomery, Christopher J. Colvin, Barbara Mensch, Ariane van der Straten

Published in: AIDS and Behavior | Issue 4/2016

Login to get access

Abstract

We investigated condom and lubricant use, rectal cleansing and rectal gel use for penile-anal intercourse (PAI), during in-depth interviews with women from South Africa, Uganda and Zimbabwe who formerly participated in VOICE, a five-arm HIV prevention trial of two antiretroviral tablets and a vaginal gel. Few studies have addressed practices related to PAI among women; existing data from Africa on condom and lubricant use for PAI, as well as preparatory practices of PAI such as rectal cleansing, are limited to men who have sex with men. Women demonstrated a lack of awareness of HIV transmission risks of PAI and none of the participants reported using condom-compatible lubricants for PAI. Participants described a variety of preparatory rectal cleansing practices. Some participants disclosed rectal use of the vaginal study gel. Understanding practices related to PAI in Africa is critical to microbicide development, as these practices are likely to influence the acceptability, feasibility, and use of both vaginal and rectal microbicide products.
Literature
2.
go back to reference Halperin DT. Heterosexual anal intercourse: prevalence, cultural factors, and HIV infection and other health risks, Part I. AIDS Patient Care STDs. 1999;13(12):717–30.CrossRefPubMed Halperin DT. Heterosexual anal intercourse: prevalence, cultural factors, and HIV infection and other health risks, Part I. AIDS Patient Care STDs. 1999;13(12):717–30.CrossRefPubMed
3.
go back to reference Kalichman SC, Simbayi LC, Cain D, Jooste S. Heterosexual anal intercourse among community and clinical settings in Cape Town, South Africa. Sex Transm Infect. 2009;85(6):411–5.CrossRefPubMedPubMedCentral Kalichman SC, Simbayi LC, Cain D, Jooste S. Heterosexual anal intercourse among community and clinical settings in Cape Town, South Africa. Sex Transm Infect. 2009;85(6):411–5.CrossRefPubMedPubMedCentral
4.
go back to reference Priddy FH, Wakasiaka S, Hoang TD, Smith DJ, Farah B, del Rio C, et al. Anal sex, vaginal practices, and HIV incidence in female sex workers in urban Kenya: implications for the development of intravaginal HIV prevention methods. AIDS Res Hum Retrovir. 2011;27(10):1067–72.CrossRefPubMedPubMedCentral Priddy FH, Wakasiaka S, Hoang TD, Smith DJ, Farah B, del Rio C, et al. Anal sex, vaginal practices, and HIV incidence in female sex workers in urban Kenya: implications for the development of intravaginal HIV prevention methods. AIDS Res Hum Retrovir. 2011;27(10):1067–72.CrossRefPubMedPubMedCentral
5.
go back to reference Exner TM, Correale J, Carballo-Dieguez A, Salomon L, Morrow KM, Dolezal C, et al. Women’s anal sex practices: Implications for formulation and promotion of a rectal microbicide. AIDS Educ Prevent. 2008;20(2):148–59.CrossRef Exner TM, Correale J, Carballo-Dieguez A, Salomon L, Morrow KM, Dolezal C, et al. Women’s anal sex practices: Implications for formulation and promotion of a rectal microbicide. AIDS Educ Prevent. 2008;20(2):148–59.CrossRef
6.
go back to reference McGowan I, Taylor DJ. Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies. Sex Transm Dis. 2010;37(6):361–4.PubMed McGowan I, Taylor DJ. Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies. Sex Transm Dis. 2010;37(6):361–4.PubMed
7.
go back to reference Mensch BS, Hewett PC, Abbott S, Rankin J, Littlefield S, Ahmed K, et al. Assessing the reporting of adherence and sexual activity in a simulated microbicide trial in South Africa: an interview mode experiment using a placebo gel. AIDS Behav. 2010;15(2):407–21.CrossRef Mensch BS, Hewett PC, Abbott S, Rankin J, Littlefield S, Ahmed K, et al. Assessing the reporting of adherence and sexual activity in a simulated microbicide trial in South Africa: an interview mode experiment using a placebo gel. AIDS Behav. 2010;15(2):407–21.CrossRef
8.
go back to reference Mâsse BR, Boily M-C, Dimitrov D, Desai K. Efficacy dilution in randomized placebo-controlled vaginal microbicide trials. Emerg Themes Epidemiol. 2009;6(1):5.CrossRefPubMedPubMedCentral Mâsse BR, Boily M-C, Dimitrov D, Desai K. Efficacy dilution in randomized placebo-controlled vaginal microbicide trials. Emerg Themes Epidemiol. 2009;6(1):5.CrossRefPubMedPubMedCentral
9.
go back to reference McGowan I. The Clinical Development of Rectal Microbicides for HIV Prevention. Doctoral thesis. University of Liverpool, Liverpool; 2013. McGowan I. The Clinical Development of Rectal Microbicides for HIV Prevention. Doctoral thesis. University of Liverpool, Liverpool; 2013.
10.
go back to reference Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol. 2010;39(4):1048–63.CrossRefPubMedPubMedCentral Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol. 2010;39(4):1048–63.CrossRefPubMedPubMedCentral
11.
go back to reference McBride KR, Fortenberry JD. Heterosexual anal sexuality and anal sex behaviors: a review. J Sex Res. 2010;47(2–3):123–36.CrossRefPubMed McBride KR, Fortenberry JD. Heterosexual anal sexuality and anal sex behaviors: a review. J Sex Res. 2010;47(2–3):123–36.CrossRefPubMed
12.
go back to reference Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis. 2002;29(1):38–43.CrossRefPubMed Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis. 2002;29(1):38–43.CrossRefPubMed
13.
go back to reference Carballo-Diéguez A, Bauermeister JA, Ventuneac A, Dolezal C, Balan I, Remien RH. The use of rectal douches among HIV-uninfected and infected men who have unprotected receptive anal intercourse: implications for rectal microbicides. AIDS Behav. 2008;12(6):860–6.CrossRefPubMedPubMedCentral Carballo-Diéguez A, Bauermeister JA, Ventuneac A, Dolezal C, Balan I, Remien RH. The use of rectal douches among HIV-uninfected and infected men who have unprotected receptive anal intercourse: implications for rectal microbicides. AIDS Behav. 2008;12(6):860–6.CrossRefPubMedPubMedCentral
14.
go back to reference Fuchs EJ, Lee LA, Torbenson MS, Parsons TL, Bakshi RP, Guidos AM, et al. Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J Infect Dis. 2007;195(5):703–10.CrossRefPubMed Fuchs EJ, Lee LA, Torbenson MS, Parsons TL, Bakshi RP, Guidos AM, et al. Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J Infect Dis. 2007;195(5):703–10.CrossRefPubMed
15.
go back to reference Javanbakht M, Stahlman S, Pickett J, LeBlanc M-A, Gorbach PM. Prevalence and types of rectal douches used for anal intercourse: results from an international survey. BMC Infect Dis. 2014;14(1):95.CrossRefPubMedPubMedCentral Javanbakht M, Stahlman S, Pickett J, LeBlanc M-A, Gorbach PM. Prevalence and types of rectal douches used for anal intercourse: results from an international survey. BMC Infect Dis. 2014;14(1):95.CrossRefPubMedPubMedCentral
16.
go back to reference Koblin BA, Mayer K, Mwatha A, Brown-Peterside P, Holt R, Marmor M, et al. Douching practices among women at high risk of HIV infection in the United States: implications for microbicide testing and use. Sex Transm Dis. 2002;29(7):406–10.CrossRefPubMed Koblin BA, Mayer K, Mwatha A, Brown-Peterside P, Holt R, Marmor M, et al. Douching practices among women at high risk of HIV infection in the United States: implications for microbicide testing and use. Sex Transm Dis. 2002;29(7):406–10.CrossRefPubMed
17.
go back to reference van der Straten A, Stadler J, Montgomery E, Hartmann M, Magazi B, et al. Women’s experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PLoS ONE. 2014;9(2):e89118.CrossRefPubMedPubMedCentral van der Straten A, Stadler J, Montgomery E, Hartmann M, Magazi B, et al. Women’s experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PLoS ONE. 2014;9(2):e89118.CrossRefPubMedPubMedCentral
18.
go back to reference Duby Z, Colvin C. Conceptualizations of heterosexual anal sex and HIV risk in five east African communities. J Sex Res. 2014;51(8):863–73.CrossRefPubMed Duby Z, Colvin C. Conceptualizations of heterosexual anal sex and HIV risk in five east African communities. J Sex Res. 2014;51(8):863–73.CrossRefPubMed
19.
go back to reference Marston C, Lewis R. Anal heterosex among young people and implications for health promotion: a qualitative study in the UK. BMJ Open. 2014;4(8):e004996.CrossRefPubMedPubMedCentral Marston C, Lewis R. Anal heterosex among young people and implications for health promotion: a qualitative study in the UK. BMJ Open. 2014;4(8):e004996.CrossRefPubMedPubMedCentral
20.
go back to reference Stadler JJ, Delany S, Mntambo M. Sexual coercion and sexual desire: Ambivalent meanings of heterosexual anal sex in Soweto. South Africa. AIDS Care. 2007;19(10):1189–93.CrossRefPubMed Stadler JJ, Delany S, Mntambo M. Sexual coercion and sexual desire: Ambivalent meanings of heterosexual anal sex in Soweto. South Africa. AIDS Care. 2007;19(10):1189–93.CrossRefPubMed
21.
go back to reference Maynard E, Carballo-Diéguez A, Ventuneac A, Exner T, Mayer K. Women’s experiences with anal sex: motivations and implications for STD prevention. Perspect Sex Reprod Health. 2009;41(3):142–9.CrossRefPubMed Maynard E, Carballo-Diéguez A, Ventuneac A, Exner T, Mayer K. Women’s experiences with anal sex: motivations and implications for STD prevention. Perspect Sex Reprod Health. 2009;41(3):142–9.CrossRefPubMed
22.
go back to reference Houston AM, Fang J, Husman C, Peralta L. More than just vaginal intercourse: anal intercourse and condom use patterns in the context of “main” and ‘casual’ sexual relationships among urban minority adolescent females. J Pediatr Adolesc Gynecol. 2007;20(5):299–304.CrossRefPubMed Houston AM, Fang J, Husman C, Peralta L. More than just vaginal intercourse: anal intercourse and condom use patterns in the context of “main” and ‘casual’ sexual relationships among urban minority adolescent females. J Pediatr Adolesc Gynecol. 2007;20(5):299–304.CrossRefPubMed
23.
go back to reference Alexander M, Mainkar M, Deshpande S, Chidrawar S, Sane S, Mehendale S. Heterosexual anal sex among female sex workers in high HIV prevalence states of India: need for comprehensive intervention. PLoS ONE. 2014;9(2):e88858.CrossRefPubMedPubMedCentral Alexander M, Mainkar M, Deshpande S, Chidrawar S, Sane S, Mehendale S. Heterosexual anal sex among female sex workers in high HIV prevalence states of India: need for comprehensive intervention. PLoS ONE. 2014;9(2):e88858.CrossRefPubMedPubMedCentral
24.
go back to reference Decker MR, Pearson E, Illangasekare SL, Clark E, Sherman SG. Violence against women in sex work and HIV risk implications differ qualitatively by perpetrator. BMC Public Health. 2013;13(1):1.CrossRef Decker MR, Pearson E, Illangasekare SL, Clark E, Sherman SG. Violence against women in sex work and HIV risk implications differ qualitatively by perpetrator. BMC Public Health. 2013;13(1):1.CrossRef
25.
go back to reference Silverman BG, Gross TP. Use and effectiveness of condoms during anal intercourse: a review. Sex Transm Dis. 1997;24(1):11–7.CrossRefPubMed Silverman BG, Gross TP. Use and effectiveness of condoms during anal intercourse: a review. Sex Transm Dis. 1997;24(1):11–7.CrossRefPubMed
26.
go back to reference Geibel S. Condoms and condiments: compatibility and safety of personal lubricants and their use in Africa. J Int AIDS Soc. 2013;16:18531.CrossRef Geibel S. Condoms and condiments: compatibility and safety of personal lubricants and their use in Africa. J Int AIDS Soc. 2013;16:18531.CrossRef
27.
go back to reference Gorbach PM, Weiss RE, Fuchs E, Jeffries RA, Hezerah M, Brown S, et al. The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk. Sex Transm Dis. 2012;39(1):59.CrossRefPubMedPubMedCentral Gorbach PM, Weiss RE, Fuchs E, Jeffries RA, Hezerah M, Brown S, et al. The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk. Sex Transm Dis. 2012;39(1):59.CrossRefPubMedPubMedCentral
28.
go back to reference Saethre EJ, Stadler J. Gelling medical knowledge: innovative pharmaceuticals, experience, and perceptions of efficacy. Anthropol Med. 2010;17(1):99–111.CrossRefPubMed Saethre EJ, Stadler J. Gelling medical knowledge: innovative pharmaceuticals, experience, and perceptions of efficacy. Anthropol Med. 2010;17(1):99–111.CrossRefPubMed
29.
go back to reference Peltzer K, Mngqundaniso N, Petros G. A controlled study of an HIV/AIDS/STI/TB intervention with traditional healers in KwaZulu-Natal. South Africa. AIDS Behav. 2006;10(6):683–90.CrossRefPubMed Peltzer K, Mngqundaniso N, Petros G. A controlled study of an HIV/AIDS/STI/TB intervention with traditional healers in KwaZulu-Natal. South Africa. AIDS Behav. 2006;10(6):683–90.CrossRefPubMed
30.
go back to reference Leyva FJ, Bakshi RP, Fuchs EJ, Li L, Caffo BS, Goldsmith AJ, et al. Isoosmolar enemas demonstrate preferential gastrointestinal distribution, safety, and acceptability compared with hyperosmolar and hypoosmolar enemas as a potential delivery vehicle for rectal microbicides. AIDS Res Hum Retrovir. 2013;29(11):1487–95.CrossRefPubMedPubMedCentral Leyva FJ, Bakshi RP, Fuchs EJ, Li L, Caffo BS, Goldsmith AJ, et al. Isoosmolar enemas demonstrate preferential gastrointestinal distribution, safety, and acceptability compared with hyperosmolar and hypoosmolar enemas as a potential delivery vehicle for rectal microbicides. AIDS Res Hum Retrovir. 2013;29(11):1487–95.CrossRefPubMedPubMedCentral
31.
go back to reference Dezzutti CS, Shetler C, Mahalingam A, Ugaonkar SR, Gwozdz G, Buckheit KW, et al. Safety and efficacy of tenofovir/IQP-0528 combination gels: a dual compartment microbicide for HIV-1 prevention. Antivir Res. 2012;96(2):221–5.CrossRefPubMedPubMedCentral Dezzutti CS, Shetler C, Mahalingam A, Ugaonkar SR, Gwozdz G, Buckheit KW, et al. Safety and efficacy of tenofovir/IQP-0528 combination gels: a dual compartment microbicide for HIV-1 prevention. Antivir Res. 2012;96(2):221–5.CrossRefPubMedPubMedCentral
32.
go back to reference Ham A, Lustig W, Nugent S, Peters J, Katz D, Shelter C, et al. Formulation development of the DuoGel: a dual chamber vaginal/rectal anti-HIV microbicide gel. In: American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, Abstr. R6132, 2013. Ham A, Lustig W, Nugent S, Peters J, Katz D, Shelter C, et al. Formulation development of the DuoGel: a dual chamber vaginal/rectal anti-HIV microbicide gel. In: American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, Abstr. R6132, 2013.
Metadata
Title
Condoms, Lubricants and Rectal Cleansing: Practices Associated with Heterosexual Penile-Anal Intercourse Amongst Participants in an HIV Prevention Trial in South Africa, Uganda and Zimbabwe
Authors
Zoe Duby
Miriam Hartmann
Elizabeth T. Montgomery
Christopher J. Colvin
Barbara Mensch
Ariane van der Straten
Publication date
01-04-2016
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2016
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-015-1120-0

Other articles of this Issue 4/2016

AIDS and Behavior 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.